Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks (Q85179320)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 October 2010

Language	Label	Description	Also known as
English	Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks	scientific article published on 30 October 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

avian influenza

1 reference

based on heuristic

inferred from title

author name string

Qingxia Yao

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Karl P Fischer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Lena Li

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Babita Agrawal

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Yohannes Berhane

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

D Lorne Tyrrell

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Klaus S Gutfreund

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

John Pasick

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

30 October 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

51

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

8147-8156

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Global patterns of influenza a virus in wild birds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Influenza A viruses of migrating wild aquatic birds in North America.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Characterization of a highly pathogenic H5N1 avian influenza A virus isolated from duck meat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Pathogenicity of H5 influenza viruses for ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Domestic ducks and H5N1 influenza epidemic, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Free-grazing ducks and highly pathogenic avian influenza, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Highly pathogenic avian influenza (H5N1) in the commercial domestic ducks of South Korea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Strategies and challenges for eliciting immunity against avian influenza virus in birds.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Effect of vaccination on transmission of HPAI H5N1: the effect of a single vaccination dose on transmission of highly pathogenic avian influenza H5N1 in Peking ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Field study on the use of inactivated H5N2 vaccine in avian species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDR

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Immunologic responses to West Nile virus in vaccinated and clinically affected horses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Epidermal DNA vaccine for influenza is immunogenic in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

DNA vaccines: ready for prime time?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The molecular architecture of the TNF superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

TNF/TNFR family members in costimulation of T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Molecular mechanism and function of CD40/CD40L engagement in the immune system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Recent advances on the role of CD40 and dendritic cells in immunity and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Humoral immune responses in CD40 ligand-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The role of CD40 and CD154/CD40L in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Identification and characterization of functional CD154 (CD40 ligand) in the Pekin duck

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Wild bird influenza survey, Canada, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Susceptibility of Canada Geese (Branta canadensis) to highly pathogenic avian influenza virus (H5N1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

Efficacy of a commercial inactivated H5 influenza vaccine against highly pathogenic avian influenza H5N1 in waterfowl evaluated under field conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.081

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.09.081

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937323%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85179320&oldid=1933724582"